AstraZeneca PLC
AZNDrug Manufacturers - GeneralOpen
171.37-0.4%Up to 1000x leverageTrade AZN
What it reported
Reported 92 days ago, on 2026-07-27.
Forecast against the result
| Forecast | Reported | Surprise | |
|---|---|---|---|
| Revenue | 15.4B | 15.4B+6.4% year on year | -0.3% |
| Net income | 3.9B | 2.5B+2.3% year on year | -35.1% |
| Earnings per share | 2.50 | 2.63+20.6% year on year | +5.2% |
Year on year compares the same quarter a year earlier (2025-07-29), not the quarter before.
AZN trades at up to 1000x here. At 1000x, a 0.10% move against you wipes out the whole margin. This ignores fees, funding and maintenance margin, all of which bring liquidation forward. Your actual liquidation price is the one shown on the order page.
You can hold through the announcement here
AZN is quoted here 24 hours a day and does not stop when the US market closes. On a US exchange the same news only shows up as a gap at the next open.
What the market expects
For the quarter ending 2026-09-30.
Against the same quarter last year (2025-11-06): EPS +8.8%revenue +5.4%
These are third-party analyst forecasts. CoinUnited.io does not produce them and does not choose which analysts are included.
Where the revenue comes from
- Total Oncology25.8%4.4B
- Farxiga8.9%1.5B
- Tagrisso8.8%1.5B
- BioPharmaceuticals: total Respiratory & Immunolo8.7%1.5B
- Imfinzi6.3%1.1B
- Soliris4.8%814.0M
Most recent reported quarter (2023-06-30). 32 smaller lines not shown.
Track record
Next report expected 2026-10-30. Reports quarterly.
Beat estimates 7 of the last 8 quarters. 1 came in exactly at forecast.The typical gap is +0.04 per share.
How much it actually moves
±2.8%
Median move across the two sessions around the report, over its last 8 results. On an ordinary two-day stretch it moves 1.2%.
2026-07-27+2.94%
2024-11-12Move over the two sessions around each report2026-07-27
Beat or miss, then up or down
| Rose | Fell | |
|---|---|---|
| Beat | 7 | 0 |
| Missed | 0 | 0 |
Counted across 8 results. This is what happened, not what will. 1 of these landed exactly on forecast, or the share price ended exactly flat, so the four cells above add up to less than 8.
Reported results
| Reported | EPS forecast | EPS actual | Surprise | Revenue surprise |
|---|---|---|---|---|
| 2026-07-27 | 2.5 | 2.63 | +5.2% | -0.3% |
| 2026-04-29 | 2.57 | 2.58 | +0.4% | +2.4% |
| 2026-02-10 | 2.09 | 2.12 | +1.4% | +0.4% |
| 2025-11-06 | 2.28 | 2.38 | +4.4% | +2.8% |
| 2025-07-29 | 2.18 | 2.18 | 0.0% | +2.5% |
| 2025-04-29 | 2.2 | 2.48 | +12.7% | -1.6% |
| 2025-02-06 | 2.07 | 2.1 | +1.4% | +4.7% |
| 2024-11-12 | 2.02 | 2.08 | +3.0% | +3.7% |
| 2024-07-25 | 1.92 | 1.98 | +3.1% | +2.5% |
| 2024-04-25 | 1.9 | 2.06 | +8.4% | +7.5% |
| 2024-02-08 | 1.48 | 1.46 | -1.4% | -0.5% |
| 2023-11-09 | 0.843 | 0.865 | +2.6% | -0.5% |
Also reporting this fortnight in Drug Manufacturers - General
ABBV 
AMGN 
BMY 
GILD 
GSK 
LLY 4 more in Drug Manufacturers - General
EPS history for AZN runs from 1997-03-21 to 2026-07-27, 108 reports.Reaction history covers its last 8 results, which is as deep as our daily price baseline reaches.